I'm LongbridgeAI, I can summarize articles.Medtronic announced an exchange offer to split off at least 80.1% of MiniMed shares, aiming to establish the diabetes business as an independent entity. Shareholders can exchange Medtronic stock for MiniMed shares at a 7% discount. The move allows Medtronic to focus on cardiovascular, neuroscience, and surgical portfolios while enabling MiniMed independent operations. Following the announcement, Medtronic's stock rose 3.44% in pre-market trading.
Add 
as your preferred news source on Google
Add Now
Monday, Medtronic plc (MDT) announced the commencement of an exchange offer to split off at least 80.1% of the shares of MiniMed Group, Inc. (MMED), reflecting confidence in its former diabetes business as an independent company.
Medtronic is offering to exchange up to 225,361,295 shares of MiniMed common stock from its current holding of 252,813,348 shares. If the exchange offer becomes oversubscribed, Medtronic currently intends to exchange an additional 27,452,053 shares of MiniMed common stock without extending the exchange offer period, representing all of Medtronic's remaining interest in MiniMed.
Medtronic shareholders can exchange their Medtronic ordinary shares for MiniMed common stock at a 7% discount through the offer. The exchange is subject to an upper limit of 4.5939 shares of MiniMed common stock per Medtronic ordinary share tendered and accepted.
If the upper limit does not apply, shareholders tendering shares are expected to receive approximately $107.53 of MiniMed common stock for every $100 of Medtronic ordinary shares tendered.
As an independent company, MiniMed can operate with its own focus, while Medtronic can allocate capital toward its Cardiovascular, Neuroscience, and Surgical portfolios.
In pre-market hours, MDT was trading at $94.11, up 3.44 percent on the NYSE.
For comments and feedback contact: editorial@rttnews.com
Business News